Antares Therapeutics
AntaresRX
Boston, United States · Founded 2025 · $177.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2025
- Business Model
- B2B
- Website
- antaresrx.com
- Total Funding
- $177.0M
- Last Round
- $177.0M Series AJun 2025
- Rounds
- 1
About
Antares Therapeutics is a precision oncology company developing first-in-class small molecule drugs for cancer and serious diseases. Built on the discovery capabilities established at Scorpion Therapeutics, Antares integrates proprietary medicinal chemistry, functional genomics, and predictive computational sciences to pursue previously undruggable targets and accelerate drug candidates to the clinic.
Summary
Antares Therapeutics is a Biotech company based in Boston, United States, founded in 2025. It has raised $177.0M in total across 1 round, most recently a $177.0M Series A round in Jun 2025. Investors include Omega Funds, Atlas Venture and Lightspeed VP.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...